Mon, Mar 2, 2015, 6:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vringo, Inc. Message Board

edvacourt 9 posts  |  Last Activity: Jan 28, 2015 1:46 PM Member since: Oct 23, 2012
  • Very good call. Being more conservative would have served them well last year. They had explosive growth but because they ridiculously blue skied their numbers they paid a price when they should have been applauded. Regardless, I'll take better than 40% growth for 2015 all day long. Once the Q1 orders are announced (who they are) this will really gain steam. Should have bounced anyway in my view but people go into these calls with expectations about what will be said and if the stock doesn't pop they sell. After we get the passive guys out this will move up. My opinion only.

    Sentiment: Strong Buy

  • edvacourt edvacourt Jan 28, 2015 1:33 PM Flag

    It's an exercise in futility to do that. That is the problem with stock investments these days. Anyone with a "fund" who has a plausible background can scream fire about any stock. Since Left's entire take was backward looking, and PLUG's history was ugly, it had legs. The only way for PLUG to stay relevant over the long term is to produce. They do need to hit their numbers and they should have been smart enough to know that when they got too feverish with their estimates last year. The blame for that is squarely on Andy. No way this stock shouldn't be up after the call I heard but it will be for sure after he announces the first of the two Q1 orders.

    Sentiment: Strong Buy

  • edvacourt by edvacourt Dec 31, 2014 11:57 AM Flag

    Great news released in 8-K this morning on the Ebola Study. The FDA doesn't approve stuff like that unless there is justification for it. Remember that the DETECT CTE study results are due out in January in coordination with Boston University. Keep in mind there has never been a way to test for that disease on live patients, only autopsy. That will be yet another breakthrough. Best to all in 2015!

    Sentiment: Strong Buy

  • edvacourt edvacourt Dec 10, 2014 1:14 PM Flag

    I only go by what has been documented and what seem like theoretical next steps. I do speculate about what should happen given a certain set of facts (or should be among a group of things that should happen), next. My point regarding the Hemopurifier is that it is clearly NOT an unknown entity here. Its safety is pretty well documented and its efficacy sure seems likely (even according to a couple of Emory doctors who are working on what may best be described as a competitive treatment). It is also an adjunct treatment which means it can and should be used in all or almost all of these cases where its proper administration may be assured. Viral load reduction is appropriate for ANYONE who is fighting infectious diseases. Unless someone can convince me this 100% does not work, and published results from a level 4 biohazard lab mean much more to me than those who write with dubious motives, then I will scream from the hilltops for more hospitals that are treating these patients here and abroad to use it as common practice for all these diseases.

    Sentiment: Strong Buy

  • Sometime in the next 24 hours I will release an article which will discuss the Ebola funding provisions in the budget that is due to be voted on by Congress tomorrow. I want to let people know that there are numerous public companies that are likely to impacted by this from those offering drugs and other treatments like Hemopurifier therapy to protective wear, thermometers, high powered cleansing solutions, waste disposal and so on. It is important to note that the world often follows the lead of the U.S. government so we are very likely to see more health agencies and governments around the world follow suit. If you do not subscribe to my blog, edvadailydotcom, please do so and when it is released you will be notified.

    Sentiment: Strong Buy

  • Reply to

    I Told You This Was Coming

    by edvacourt Dec 9, 2014 10:13 AM
    edvacourt edvacourt Dec 9, 2014 10:55 AM Flag

    Not everyone will sit and wait anymore. Some company will now jump in and help them cross the finish line. They are too close and there are too many benefits available for the company that partners with them.

    Sentiment: Strong Buy

  • This is why you need to have some patience with science. I will have a write-up on this in just a little while. This is earth shattering news and I think people will continue to wake up to its significance in the days and weeks ahead. For the first time we may see major news coverage of HYSR. Of course no one can guarantee that but I see it as likely.

    Sentiment: Strong Buy

  • edvacourt edvacourt Dec 3, 2014 1:40 PM Flag

    I don't think there is enough information available about timing and commercialization efforts to offer something that is really fair. I can definitely say that the latest See Thru Equity price target is pretty low. I will detail some of my thinking tomorrow and you should have a better sense.

    Sentiment: Strong Buy

  • I have written several articles about Aethlon on my blog, edvadailydotcom, and for those wondering what to do rather than watching the tape trying to figure out when to get in or reflexively get out because you are ill informed about the investment and what this company does (or don't know what is directly ahead) you probably need to consider some important points that loom pretty large in the future:

    -35 Hospitals in the U.S. were designated yesterday to treat future Ebola patients. There is a $150M plus earmark in the spending bill, that Congress (in theory) must pass by December 11 to continue funding the government, for these U.S. hospitals to, in part, be outfitted with the best equipment to deal with these patients. Hard to imagine that the Hemopurifier will not be part of that equation and may well be why the company sought to raise what it did so quickly.

    -Kick off of the FDA authorized human trials for HCV patients in the U.S.

    -Update from the company on pathways to commercialization. This is what many are wanting to get a first look at in some broader yet nonetheless comprehensive way. Our assumption is that we will see this in coming weeks.

    These items are just a sampling of the obvious. I have been surprised on several occasions lately in terms of positive items that come up unexpectedly. The Time Magazine recognition stands out and in my view has created the kind of interest in the company where it would be impossible to guess at the number of conversations they are having with interested parties on multiple levels be they potential partners, health organizations or governments. I am by no means telling anyone that they should buy anything but if you are caught looking today you may miss the forest for the trees.

    Lastly, I will be posting an article at some point tomorrow morning which I think many may find interesting. As always do your own due diligence or consult with a trusted financial advisor prior to buying any equity.

    Sentiment: Strong Buy

VRNG
0.7885+0.0908(+13.01%)Mar 2 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.